SPORTSMEDUPDATE
SportsMedUpdate
University of Cape Town, South Africa
| The first 150 words of the full text of this article appear below. |
Robinson P, Keenan AM, Conaghan PG. Rheumatology 2007;46:285–29
There are limited data on the effectiveness of differing doses of intra-articular corticosteroid injection on reducing pain, stiffness and disability in patients with hip osteoarthritis.
Does either intra-articular steroid treatment (IAST) injection of either 40 or 80 mg improve pain, stiffness and disability over 12 weeks in patients with osteoarthritis of the hip?
Subjects: 120 patients with osteoarthritis of the hip (90 female 30 men; median age 64 years)
Experimental procedure: Subjects were referred for IAST (fluoroscopic guidance). All subjects underwent WOMAC scores, body mass index (BMI), conventional radiographic grade (Kellgren and Lawrence scoring) and ultrasound measures (including capsular thickness and osteophyte assessments) at baseline, 6 and 12 weeks. In phase 1 of the study, 75 patients were injected with 40 mg methylprednisolone (40 mg group), and then 45 patients were injected with 80 mg in phase 2 (80 mg group).
Measures
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
